USPTO 2015–2025 USPTO PatentsView US Corporation

Valo Health, Inc.

USPTO PatentsView assignee record - 29 granted patents across 5 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

29
Total patents granted
5
CPC technology areas
16.7
Avg claims per patent
-
5-year grant velocity

The verdict

According to USPTO PatentsView, Valo ranks #10,811 of 50,000 tracked US assignees by granted-patent volume, with 29 patents across 5 technology areas.

#10,811
of 50,000 US assignees by volume
Top 14%
by Innovation Score (49.7/100)
16.7
avg claims per patent

Portfolio overview

Valo Health, Inc. has been granted 29 US utility patents between 2020 and 2025, placing Valo Health, Inc. at #10,811 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.7 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, Valo Health, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Valo sits between Upside Foods, Inc. (29 patents, rank #10,808) and Wellfine Silicone Products Co., Ltd. (29 patents, rank #10,816) - the closest US assignees by grant volume. The composite Innovation Score of 49.7/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Historical data spans 2020 through 2025, with 29 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Valo Health, Inc.'s 16.7 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 5 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Who files at Valo's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Valo holds 29 patents at rank #10,812, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Valo

By rank, the assignees closest to #10,812 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Valo's primary technology class.

Valo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 20202022202320242025 5
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Valo Health, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 3.4%
2022 11 37.9%
2023 6 20.7%
2024 6 20.7%
2025partial year 5 17.2%

Grant record at a glance

Portfolio Volume 29 grants
CPC subclasses 5
Avg. claims / grant 16.7

Historical grant data only; it does not rate legal strength or current strategy.

Where it ranks

Overall rank by patents

#10,811

of 50,000 tracked assignees

Innovation Score

49.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

Where does Valo Health, Inc. rank among US patent assignees?
According to USPTO PatentsView (2015–2025 granted utility patents), Valo Health, Inc. ranks #10,811 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.
How many patents does Valo Health, Inc. hold?
Valo Health, Inc. holds 29 US utility patents granted between 2020 and 2025, spanning 5 technology areas.
What is Valo Health, Inc.'s Innovation Score?
Valo Health, Inc. has an Innovation Score of 49.7 out of 100 (top 14% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Valo Health, Inc. focus on?
Valo Health, Inc.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 29 patents. Grants appear in 5 CPC subclasses total.
Is Valo Health, Inc.'s patent grant rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Valo Health, Inc..
What does claim depth mean for Valo Health, Inc.'s patents?
Valo Health, Inc.'s patents average 16.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.
How is the Valo Health, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Valo's 29 grants land it in the top 14% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Valo ranks #10,811 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.